Molecular Diagnostics


Mycobacterium Mutations Associated with Clarithromycin Resistance
Mycobacterium abscessus is a leading cause of respiratory diseases and soft tissue infections and it is naturally resistant to many antibiotics in vitro, which complicates clinical treatment and leads to unsatisfactory results. More...09 Jan 2018





Genomic Test Predicts Survival Rates after Cardiac Surgery
Mechanical circulatory support (MCS) devices, such as ventricular assist devices and temporary total artificial hearts, can be surgically implanted in people with advanced heart failure to help the heart's pumping function. More...28 Dec 2017
In Other News
Digital PCR Test Monitors CML Therapy Response
Genetic Test Recommended for Inherited Prostate Cancer
Genetic Profile Identified for Dementia with Lewy Bodies
DNA Methylation Pattern Predicts Remission in Rare Juvenile Leukemia
Researchers Develop Metabolomics Approach for Diagnosing MS
Multiple Myeloma Survival Associated with Enzyme Levels
Phenocopies Found in Melanoma-Prone Families
New Assay Predicts Cancerous Pancreatic Lesions
Rapid POC Assay Detects Micronutrient Deficiencies
Detection of Circulating DNA Predicts Poor Prognosis
Multiplexed Amplification Evaluated for Viral Hemorrhagic Fever Diagnostics
Five New Genes Identified for ALS
Single Cell Genomics Utilized for Evaluation of Prostate Cancer
Genetic Link Found Between Immune System and Lymphoma
Missing DNA Fragments Could Predict Leukemia Relapse
Genetic Testing Unravels Unusual Patterns for Fragile-X Syndrome
Whole Exome Sequencing Offers Clinical Value in Diagnosing CKD
Dipstick Technology Could Revolutionize Disease Diagnosis
Prion Protein Found in Skin of CJD Patients
Metabolites Altered in Chronic Kidney Disease
HLF-Gene Controls Generation of Immune System
Immune Tolerance Level Predicts Leukemia Outcome
Enzyme Boosts Power of Liquid Biopsies to Detect Cancers
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.